Scientists discover new mutations in the 'immunity gene'
An infant’s odd case of encephalitis, not typically found in children, has led Japanese researchers to discover never-before-seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity. Their work has been published in the Journal of Clinical Immunology.
The IRAK4 gene instructs the production of a protein that plays a key role in the early recognition and response to invading pathogens. Inherited mutations in this gene can cause an immune system disorder that leaves the body susceptible to recurrent infections of pus-forming pyogenic bacteria. Cases of IRAK4 deficiency are quite rare and only about 10 familial instances have been identified so far in Japan.
Led by Hiroshima University, researchers detected two novel IRAK4 mutations — c.29_30delAT (p.Y10Cfs*9) and c.35G>C (p.R12P) — in a 10-month-old boy with anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis and human herpesvirus 6 (HHV6) reactivation. The p.Y10Cfs*9 and p.R12P variations were inherited from his father and mother, respectively. The research team found the mutations by using whole exome sequencing (WES), a method used to exhaustively examine the DNA for genetic disorders.
Anti-NMDAR encephalitis, an inflammation of the brain, happens when the immune system attacks a vital brain receptor, causing psychiatric symptoms, involuntary movement, seizures, autonomic dysfunction and central hypoventilation. It typically occurs in adult females suffering from ovarian tumour — only a few cases of anti-NMDAR encephalitis have been so far reported in infants — but the researchers suspect that reactivation of HHV6 may have induced brain damage that triggered the production of anti-NMDAR antibodies.
“It is well known that anti-NMDAR encephalitis is triggered by HSV1 (herpes simplex virus) infection,” the researchers wrote. “The post-infectious autoimmune process that follows the HSV-induced brain damage is thought to be the cause of anti-NMDAR encephalitis.
“The coexistence of anti-NMDAR encephalitis and HHV6 reactivation in this patient may reveal an unknown manifestation associated with IRAK4 deficiency.”
Although the researchers have yet to find direct evidence demonstrating a relationship between IRAK4 deficiency and the development of anti-NMDAR encephalitis or HHV6 reactivation, they were able to establish that mutations p.Y10Cfs*9 and p.R12P are damaging. By developing a novel NF-κB reporter assay that can precisely evaluate whether an IRAK4 mutation is harmful, the researchers were able to investigate the activation of transcription factor NF-κB, which regulates the body’s inflammatory responses.
“Using this system, we confirmed that both novel mutations are deleterious. The current case revealed the possibility that genetics can contribute to characterising infantile cases with anti-NMDAR encephalitis,” said Hiroshima’s Satoshi Okada, a co-author on the study.
The team resolved potential issues of misevaluation in a previously developed NF-κB reporter assay by using CRISPR gene-editing technology to remove the IRAK4 naturally expressed in the HEK293 cell — commonly used in studying gene function as it is much easier to transfect than other cell lines.
“HEK293 cells have endogenous IRAK4 expression,” Okada said. “Their endogenous IRAK4 prevents the precise evaluation of the activity of introduced WT or mutant IRAK4.”
To date, there are so far 24 known mutations identified in patients with IRAK4 deficiency. The research team hopes to soon introduce their novel NF-κB reporter assay system to help evaluate IRAK4 gene mutations and achieve early diagnosis.
Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.
Stem cell experiments conducted in space
Scientists are one step closer to manufacturing stem cells in space — which could speed up...
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...
